"Prevention and Treatment of Virulent Bacterial Biofilms with an Enzymatic Nitric Oxide-Releasing Dressing" has now been published ahead of print on the Antimicrobial Agents and Chemotherapy website. Click here to read it now (pending subscriptions or institutional access).
Newest manuscript accepted by Antimicrobial Agents and Chemotherapy
Chris' newest manuscript has just been accepted by the peer-reviewed journal Antimicrobial Agents and Chemotheraphy. The manuscript, for which Chris is the 3rd author, is entitled "Prevention and treatment of virulent bacterial biofilms with an enzymatic nitric oxide-releasing dressing." This manuscript explores both the bactericidal and anti-biofilm potential of this dressing against Acinetobacter baumannii, methicillin-resistant Staphlococcus aureus … Continue reading Newest manuscript accepted by Antimicrobial Agents and Chemotherapy
“Suppression of MAPKAPK2 during mammalian hibernation” now in final formatted version
Chris' latest peer-reviewed publication, "Suppression of MAPKAPK2 during mammalian hibernation" is now in its corrected proof format, available on the Cryobiology website. The article is currently designated as "in press" and its final volume, issue, and page numbers will be determined on print. Find other peer-reviewed publications written by Chris here.
“Suppression of MAPKAPK2 during mammalian hibernation” now indexed by PubMed and Google Scholar
Chris' latest peer-reviewed paper, "Suppression of MAPKAPK2 during mammalian hibernation" is now being tracked by indexing sites such as PubMed and Google Scholar. Chris' publication record on PubMed can be viewed here. Chris' publication record on Google Scholar- along with other goodies such as citations, h-index, i10-index, can be viewed here.
“Suppression of MAPKAPK2 during mammalian hibernation” goes live
At the moment, it's still an uncorrected, unedited, unformatted proof, but Chris' most recent peer-reviewed publication is now available online on ScienceDirect's Cryobiology website. Read it here.
Laboratory for Evaluation of Pharmacological Agents in Remediation of Disease (LEoPARD) 